Water Tower Research Publishes Initiation of Coverage Report on Aspira Women’s Health, Inc. Titled, “Leader in Ovarian Cancer Detection; Initiating Coverage of Aspira Women’s Health”

Press Release May 18, 2023

May 18, 2023, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Aspira Women’s Health, Inc. (NASDAQ: AWH) titled, “Leader in Ovarian Cancer Detection; Initiating Coverage of Aspira Women’s Health”. The report can […]

Tag: FDA approved diagnostic tests

Water Tower Research Publishes Initiation of Coverage Report on Aspira Women’s Health, Inc. Titled, “Leader in Ovarian Cancer Detection; Initiating Coverage of Aspira Women’s Health”

Cookies & Privacy